Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Marker Therapeutics Q3 EPS $(0.34) Up From $(0.80) YoY, Sales $257.61K Down From $3.95M YoY

Author: Benzinga Newsdesk | November 09, 2023 08:03pm
Marker Therapeutics (NASDAQ:MRKR) reported quarterly losses of $(0.34) per share. This is a 57.5 percent increase over losses of $(0.80) per share from the same period last year. The company reported $257.61 thousand in sales this quarter. This is a 93.48 percent decrease over sales of $3.95 million the same period last year.

Posted In: MRKR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist